MEI Pharma, Inc.

NasdaqCM:MEIP 주식 보고서

시가총액: US$19.3m

이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!

MEI Pharma 미래 성장

Future 기준 확인 0/6

MEI Pharma 의 수익과 수익은 각각 연간 30.7% 및 51% 감소할 것으로 예상됩니다. EPS는 연간 44.4% 만큼 쇠퇴할 것으로 예상됩니다.

주요 정보

-35.5%

수익 성장률

-22.8%

EPS 성장률

Biotechs 수익 성장28.5%
매출 성장률-26.2%
향후 자기자본 수익률n/a
애널리스트 커버리지

Low

마지막 업데이트23 Jul 2024

최근 미래 성장 업데이트

Recent updates

New Forecasts: Here's What Analysts Think The Future Holds For MEI Pharma, Inc. (NASDAQ:MEIP)

Feb 17
New Forecasts: Here's What Analysts Think The Future Holds For MEI Pharma, Inc. (NASDAQ:MEIP)

Increases to CEO Compensation Might Be Put On Hold For Now at MEI Pharma, Inc. (NASDAQ:MEIP)

Dec 30
Increases to CEO Compensation Might Be Put On Hold For Now at MEI Pharma, Inc. (NASDAQ:MEIP)

Need To Know: Analysts Are Much More Bullish On MEI Pharma, Inc. (NASDAQ:MEIP)

Nov 19
Need To Know: Analysts Are Much More Bullish On MEI Pharma, Inc. (NASDAQ:MEIP)

We're Hopeful That MEI Pharma (NASDAQ:MEIP) Will Use Its Cash Wisely

May 18
We're Hopeful That MEI Pharma (NASDAQ:MEIP) Will Use Its Cash Wisely

Need To Know: The Consensus Just Cut Its MEI Pharma, Inc. (NASDAQ:MEIP) Estimates For 2022

Mar 26
Need To Know: The Consensus Just Cut Its MEI Pharma, Inc. (NASDAQ:MEIP) Estimates For 2022

Newsflash: MEI Pharma, Inc. (NASDAQ:MEIP) Analysts Have Been Trimming Their Revenue Forecasts

Feb 12
Newsflash: MEI Pharma, Inc. (NASDAQ:MEIP) Analysts Have Been Trimming Their Revenue Forecasts

MEI Pharma: Another PI3K Delta Progressing To The FDA

Feb 01

Need To Know: Analysts Just Made A Substantial Cut To Their MEI Pharma, Inc. (NASDAQ:MEIP) Estimates

Dec 02
Need To Know: Analysts Just Made A Substantial Cut To Their MEI Pharma, Inc. (NASDAQ:MEIP) Estimates

We're Not Very Worried About MEI Pharma's (NASDAQ:MEIP) Cash Burn Rate

Nov 04
We're Not Very Worried About MEI Pharma's (NASDAQ:MEIP) Cash Burn Rate

MEI Pharma EPS misses by $0.12, misses on revenue

May 06

MEI Pharma promotes Richard Ghalie to chief medical officer

Apr 30

MEI Pharma shares rise 4% as Wells Fargo says voruciclib undervalued

Apr 26

The Independent Non-Executive Director of MEI Pharma, Inc. (NASDAQ:MEIP), Frederick Driscoll, Just Sold 40% Of Their Holding

Feb 25
The Independent Non-Executive Director of MEI Pharma, Inc. (NASDAQ:MEIP), Frederick Driscoll, Just Sold 40% Of Their Holding

New Forecasts: Here's What Analysts Think The Future Holds For MEI Pharma, Inc. (NASDAQ:MEIP)

Feb 11
New Forecasts: Here's What Analysts Think The Future Holds For MEI Pharma, Inc. (NASDAQ:MEIP)

수익 및 매출 성장 예측

NasdaqCM:MEIP - 애널리스트의 미래 추정치 및 과거 재무 데이터 (USD Millions )
날짜수익수익잉여 현금 흐름작전 현금평균 애널리스트 수
6/30/202725-31N/AN/A1
6/30/202625-26N/AN/A1
6/30/20256-40N/AN/A2
6/30/20246518-50-50N/A
3/31/20246726-44-44N/A
12/31/20237320-53-53N/A
9/30/202310541-56-56N/A
6/30/202349-32-53-52N/A
3/31/202359-38-57-57N/A
12/31/202263-31-62-62N/A
9/30/202242-54-56-56N/A
6/30/202241-54-49-49N/A
3/31/202237-47-45-44N/A
12/31/202135-64-43-43N/A
9/30/202136-60-35-35N/A
6/30/202135-41-33-32N/A
3/31/202152-534848N/A
12/31/202045-315254N/A
9/30/202033-434243N/A
6/30/202028-473334N/A
3/31/20205-24-44-43N/A
12/31/20195-38-44-44N/A
9/30/20196-5-31-31N/A
6/30/20195-17-30-29N/A
3/31/20194-39-25-25N/A
12/31/20184-28-20-20N/A
9/30/20182-46-27-27N/A
6/30/20182-40-21-21N/A
3/31/20182-25N/A-21N/A
12/31/20176-20N/A-13N/A
9/30/201722-2N/A-12N/A
6/30/2017233N/A3N/A
3/31/2017231N/A3N/A
12/31/201618-4N/A-3N/A
9/30/20161-21N/A-3N/A
6/30/2016N/A-21N/A-18N/A
3/31/2016N/A-21N/A-21N/A
12/31/2015N/A-24N/A-25N/A
9/30/2015N/A-28N/A-27N/A
6/30/2015N/A-33N/A-28N/A
3/31/2015N/A-36N/A-27N/A
12/31/2014N/A-34N/A-24N/A
9/30/2014N/A-31N/A-22N/A
6/30/2014N/A-27N/A-19N/A
3/31/2014N/A-22N/A-16N/A

애널리스트 미래 성장 예측

수입 대 저축률: MEIP 의 수익은 향후 3년간 감소할 것으로 예상됩니다(연간 -51% ).

수익 vs 시장: MEIP 의 수익은 향후 3년간 감소할 것으로 예상됩니다(연간 -51% ).

고성장 수익: MEIP 의 수익은 향후 3년간 감소할 것으로 예상됩니다.

수익 대 시장: MEIP 의 수익은 향후 3년간 감소할 것으로 예상됩니다(연간 -30.7% ).

고성장 수익: MEIP 의 수익은 향후 3년 동안 감소할 것으로 예상됩니다(연간 -30.7% ).


주당 순이익 성장 예측


미래 자기자본 수익률

미래 ROE: MEIP 의 자기자본수익률이 3년 내에 높을 것으로 예상되는지 판단하기에는 데이터가 부족합니다.


성장 기업 발견